Abstract
Alcohol appears to affect brain function, primarily by interfering with the action of gamma-aminobutyric acid (GABA) and other neurotransmitters. As alcohol is mainly metabolized in the liver, therefore we undertook this pilot study to monitor the patterns of changes in plasma amino-acid concentrations due to alcoholic and nonalcohol fatty liver disease and their relation with plasma GABA level. Plasma amino-acid concentrations were measured in 25 alcoholic liver disease (ALD) patients, 18 non-alcoholic fatty liver disease (NAFLD) patients, and 24 age and sex matched control subjects by HPLC. GABA concentration was elevated, while isoleucine and leucine levels reduced significantly in ALD patients compared to the control subjects. Methionine and phenylalanine levels elevated and valine content reduced significantly in ALD patients compared to other two groups, and GABA level was significantly correlated with methionine and phenylalanine. Plasma concentration of lysine was significantly reduced in both groups of liver disease patients compared to the control group, but was not correlated with GABA level. Glycine and tyrosine levels reduced significantly in NAFLD patients compared to other two groups and were significantly correlated with GABA. Interestingly, though amino acids such as alanine, histidine, proline and serine were not affected by liver diseases, but were significantly correlated with GABA level. This pilot study indicated that alcoholic liver disease presented a more deranged plasma amino acid pattern than nonalcoholic, and the amino acid imbalances. More studies are necessary to identify the role of any particular amino acid on brain function and on neurotransmitter(s).
Key Words: Alcohol, Amino acids, Gamma aminobutyric acid, Liver, Non-alcoholic fatty liver disease
Full Text
The Full Text of this article is available as a PDF (109.0 KB).
References
- 1.Das S.K., Balakrishnan V., Vasudevan D.M. Alcohol: Its health and social impact in India. Natl Med J India. 2006;19(2):94–99. [PubMed] [Google Scholar]
- 2.Oscar-Berman M., Shagrin B., Evert D.L., Epstein C. Impairments of brain and behavior: the neurological effects of alcohol. Alcohol Health Res World. 1997;21(1):65–75. [PMC free article] [PubMed] [Google Scholar]
- 3.Mukherjee S., Das S.K., Vaidyanthan K., Vasudevan D.M. Consequences of alcohol consumption on neurotransmitters: an overview. Curr Neurovascular Res. 2008;5(4):266–272. doi: 10.2174/156720208786413415. [DOI] [PubMed] [Google Scholar]
- 4.Das S.K., Vasudevan D.M. Alcohol induced oxidative stress. Life Sciences. 2007;81(3):177–187. doi: 10.1016/j.lfs.2007.05.005. [DOI] [PubMed] [Google Scholar]
- 5.Das S.K., Balakrishnan V., Mukherjee S., Vasudevan D.M. Evaluation of blood oxidative stress related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Scand J Clin Lab Invest. 2008;68(4):323–334. doi: 10.1080/00365510701673383. [DOI] [PubMed] [Google Scholar]
- 6.Wu C., Bollman J.L., Butt H.R. Changes in free amino acids in the plasma during hepatic coma. J Clin Invest. 1955;34:845–849. doi: 10.1172/JCI103139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Iber F.L., Rosen H., Levenson S.M., Chalmers T.C. The plasma amino acids in patients with liver failure. J Lab Clin Med. 1957;50:417–425. [PubMed] [Google Scholar]
- 8.Levine R.J., Conn H.O. Tyrosine metabolism in patients with liver disease. J Clin Invest. 1967;42:2012–2020. doi: 10.1172/JCI105690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ning M., Lowenstein L.M., Davidson C.S. Serum amino acid concentrations in alcoholic hepatitis. J Lab Clin Med. 1967;70:554–562. [PubMed] [Google Scholar]
- 10.Mata J.M., Kershenobich D., Villarreal E. Rojkind M. Serum free proline and free hydroxyproline in patients with chronic liver disease. Gastroenterol. 1975;68:1265–1269. [PubMed] [Google Scholar]
- 11.Armstrong M.D., Stave U. A study of plasma free amino acid levels. III. Variation during growth and ageing. Metabolism. 1973;22:571–578. doi: 10.1016/0026-0495(73)90070-X. [DOI] [PubMed] [Google Scholar]
- 12.Milsom J.P., Morgan M.Y., Sherlock S. Factors affecting plasma amino acid concentrations in control subjects. Metabolism. 1979;28:313–319. doi: 10.1016/0026-0495(79)90101-X. [DOI] [PubMed] [Google Scholar]
- 13.Christensen HN. I. Biological Transport. 2nd ed. Reading, Massachusetts: W A Benjamin, Inc.; 1975. [Google Scholar]
- 14.Morgan M.Y., Marshall A.W., Milsom J.P., Sherlock S. Plasma aminoacid patterns in liver disease. Gut. 1982;23:362–370. doi: 10.1136/gut.23.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hagenfeldt L., Arvidsson A. The distribution of amino acids between plasma and erythrocytes. Clin Chim Acta. 1980;100:133–141. doi: 10.1016/0009-8981(80)90074-1. [DOI] [PubMed] [Google Scholar]
- 16.Krystal J.H., Staley J., Mason G., Petrakis I.L., Kaufman J., Harris R.A., Gelernter J., Lappalainen A. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry. 2006;63:957–968. doi: 10.1001/archpsyc.63.9.957. [DOI] [PubMed] [Google Scholar]
- 17.Kretz F.J., Loscher W., Dillinger U. The blood level of gammaaminobutyric acid in patients with liver cirrhosis and portacaval anastomosis. Anaesthesiol Reanim. 1991;16(3):169–174. [PubMed] [Google Scholar]
- 18.Joelsson B., Hultberg B., Alwmark A., Gullstrand P., Bengmark S. Pattern of serum amino acids in patients with liver cirrhosis. Influence of shunt surgery and transesophageal sclerotherapy. Scand J Gastroenterol. 1984;19(4):547–551. [PubMed] [Google Scholar]
- 19.Vargas-Tank L., Wolff C., Castillo T., Carrión Y., Hoppe A., Martínez V., Arman-Merino R. Serum proline and blood lactate levels in alcoholic patients without hepatic failure: relationship with alcohol ingestion and histological activity. Liver. 1988;8(1):58–62. doi: 10.1111/j.1600-0676.1988.tb00968.x. [DOI] [PubMed] [Google Scholar]
- 20.Nakajima T., Sato A., Murayama N. [Metabolic abnormalities of amino acids in patients with alcoholic liver damage] Nippon Rinsho. 1992;50(7):1609–1613. [PubMed] [Google Scholar]
- 21.Shaw S., Worner T.M., Lieber C.S. Frequency of hyperprolinemia in alcoholic liver cirrhosis: relationship to blood lactate. Hepatol. 1984;4(2):295–299. doi: 10.1002/hep.1840040220. [DOI] [PubMed] [Google Scholar]
- 22.Shiota T., Nakatsukasa H., Fujiwara M., Takei N., Yamauchi Y., Kobayashi M., Watanabe A., Nagashima H. Plasma amino acid imbalance in alcoholic liver cirrhosis. Biochem Med. 1984;32(2):181–188. doi: 10.1016/0006-2944(84)90071-1. [DOI] [PubMed] [Google Scholar]
- 23.Vannucchi H., Marchini J.S., Padovan G.J., dos-Santos J.E., Dutra-de-Oliveira J.E. Amino acid patterns in the plasma and ascitic fluid of cirrhotic patients. Braz J Med Biol Res. 1985;18(4):465–470. [PubMed] [Google Scholar]
- 24.Kwon Y., Jung Y.S., Kim S.J., Park H.K., Park J.H., Kim Y.C. Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. J Nutr. 2009;139(1):63–68. doi: 10.3945/jn.108.094771. [DOI] [PubMed] [Google Scholar]
- 25.Kharbanda K.K. Alcoholic liver disease and methionine metabolism. Semin Liver Dis. 2009;29(2):155–165. doi: 10.1055/s-0029-1214371. [DOI] [PubMed] [Google Scholar]
- 26.Yang H.T., Chen Y.H., Chiu W.C., Huang S.Y. Effects of consecutive high-dose alcohol administration on the utilization of sulfur-containing amino acids by rats. J Nutr Biochem. 2006;17(1):45–50. doi: 10.1016/j.jnutbio.2005.05.002. [DOI] [PubMed] [Google Scholar]
- 27.Lepage N., McDonald N., Dallaire L., Lambert M. Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem. 1997;43:2397–2402. [PubMed] [Google Scholar]
- 28.Larter C.Z., Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol. 2008;23(11):1635–1648. doi: 10.1111/j.1440-1746.2008.05543.x. [DOI] [PubMed] [Google Scholar]
- 29.Bianchi G., Marchesini G., Brunetti N., Manicardi E., Montuschi F., Chianese R., Zoli M. Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistance. Dig Liver Dis. 2003;35(10):722–777. doi: 10.1016/S1590-8658(03)00416-X. [DOI] [PubMed] [Google Scholar]